Changes in Beneficial Ownership · 4
Pharvaris N.V.
PHVSNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-09-17
- Issuer
- Pharvaris N.V.
- Issuer CIK
- 0001830487
- Trading symbol
- PHVS
Reporting owner 1
- Name
- Bjork Elisabeth
- Reporting owner CIK
- 0001810406
- Relationship
- Director
- Address
- 1 CRANBERRY HILL SUITE 400, LEXINGTON, MA, 02421
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-09-17 | M · Form 4 | 35,000 | A | 14.39 | 50,167 | D |
| Common Stock | 2026-09-17 | M · Form 4 | 17,500 | A | 18.14 | 67,667 | D |
| Common Stock | 2026-09-17 | S · Form 4 | 52,500 | D | 37.8935[F1] | 15,167 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- A
- Acquired
- D
- Direct
- S · Form 4
- Sale on the market or privately
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | 14.39 | 2026-09-17 | M · Form 4 | 35,000 | D | 0 | [F2] | 2032-01-01 | Common Stock | 35,000 | 0 | D |
| Stock Option (Right to Buy) | 18.14 | 2026-09-17 | M · Form 4 | 17,500 | D | 0 | [F3] | 2032-04-01 | Common Stock | 17,500 | 0 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- D
- Direct
Footnotes
- F1
- The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $37.62 to $38.05. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.↩ 1
- F2
- 25% of the option vested on January 1, 2023 with the remaining shares vesting in 1/48 monthly installments thereafter.↩ 1
- F3
- 25% of the option vested on April 1, 2023 with the remaining shares vesting in 1/48 monthly installments thereafter.↩ 1
Signature 1
- Signed
- /s/ Marnus Nel, Attorney-in-Fact for Elisabeth Bjork
- Date
- 2026-09-21